journal article·2021

Endothelial cell membrane-based biosurface for targeted delivery to acute injury: analysis of leukocyte-mediated nanoparticle transportation

Fang Wang, Wenda Hou, Chenglu Xiao, Yaoyao Hao, Ni Su, Yu Deng, Jieting Wang, Luying Yu, Jing-Ming Xie, Jing-Wei Xiong, Ying Luo

Nanoscale· Volume 13· Issue 35
Publisher page

Abstract

Mimicking and leveraging biological structures and materials provide important approaches to develop functional vehicles for drug delivery. Taking advantage of the affinity and adhesion between the activated endothelial cells and innate immune cells during inflammatory responses, hybrid polyester nanoparticles coated with endothelial cell membranes (EM-P) containing adhesion molecules were fabricated and their capability as vehicles to travel to the acute injury sites through leukocyte-mediated processes was investigated. The in vivo studies and quantitative analyses performed through the lung-inflammation mouse models demonstrated that the EM-Ps preferentially interacted with the neutrophils and monocytes in the circulation and the cellular membrane-based biosurface improved the nanoparticle transportation to the inflamed lung possibly via the motility of neutrophils. Utilizing the transgenic zebrafish model, the leukocyte-mediated transportation and biodistribution of EM-Ps were further visualized in real time at the whole-organism level. Endothelial membranes provided a new biosurface for developing biomimetic vehicles to allow the immune cell-mediated transportation and may enable advanced systems for active and highly efficient drug delivery.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Nanomedical Technology Research Institute, Key Laboratory of Nanomedical Technology (Education Department of Fujian Province), School of Pharmacy, Fujian Medical University, Fuzhou, Fujian Province, China 350122

Department of Biomedical Engineering, College of Engineering, Peking University, Beijing, China 100871

Institute of Molecular Medicine, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, Beijing, China 100871

Department of Biomedical Engineering, Tufts University, Medford, Massachusetts, United States of America 02155

Funding

National Natural Science Foundation of China · Natural Science Foundation of Fujian Province · National Key Research and Development Program of China

References (55)

Show source-provided references
1. Ayer · J. Controlled Release · 2017 · 259 · 9210.1016/j.jconrel.2017.01.048 ↗
2. Su · ACS Biomater. Sci. Eng. · 2015 · 1 · 20110.1021/ab500179h ↗
3. Anselmo · J. Controlled Release · 2014 · 190 · 53110.1016/j.jconrel.2014.03.050 ↗
4. Tiet · Biochem. Pharmacol. · 2017 · 145 · 1810.1016/j.bcp.2017.09.006 ↗
5. Pang · Drug Delivery · 2017 · 24 · 8310.1080/10717544.2016.1230903 ↗
6. Tan · Theranostics · 2015 · 5 · 86310.7150/thno.11852 ↗
7. Dong · Theranostics · 2017 · 7 · 75110.7150/thno.18069 ↗
8. Agrahari · Expert Opin. Drug Delivery · 2017 · 14 · 28510.1080/17425247.2017.1254614 ↗
9. Mitchell · Expert Opin. Drug Delivery · 2015 · 12 · 37510.1517/17425247.2015.966684 ↗
10. Epelman · Nat. Rev. Immunol. · 2015 · 15 · 11710.1038/nri3800 ↗
11. Galli · Nat. Immunol. · 2011 · 12 · 103510.1038/ni.2109 ↗
12. Soehnlein · Nat. Rev. Immunol. · 2010 · 10 · 42710.1038/nri2779 ↗
13. Han · Small · 2018 · 14 · e180167410.1002/smll.201801674 ↗
14. Chu · Adv. Mater. · 2018 · 30 · e170624510.1002/adma.201706245 ↗
15. Aizik · Drug Delivery Transl. Res. · 2018 · 8 · 86810.1007/s13346-017-0431-2 ↗
16. Hou · Sci. Adv. · 2019 · 5 · eaau830110.1126/sciadv.aau8301 ↗
17. Zhang · Theranostics · 2017 · 7 · 326010.7150/thno.19979 ↗
18. Chu · Adv. Mater. · 2017 · 29 · 170102110.1002/adma.201701021 ↗
19. Cheng · Adv. Healthcare Mater. · 2016 · 5 · 268610.1002/adhm.201600724 ↗
20. Thanuja · Adv. Drug Delivery Rev. · 2018 · 132 · 5710.1016/j.addr.2018.06.012 ↗
21. Fang · Adv. Mater. · 2018 · 30 · 170675910.1002/adma.201706759 ↗
22. Luk · J. Controlled Release · 2015 · 220 · 60010.1016/j.jconrel.2015.07.019 ↗
23. Chen · Acta Biomater. · 2020 · 112 · 110.1016/j.actbio.2020.05.028 ↗
24. Li · Bioconjugate Chem. · 2018 · 29 · 62410.1021/acs.bioconjchem.7b00669 ↗
25. Jang · Molecules · 2017 · 22 · 219710.3390/molecules22122197 ↗
26. Li · Nat. Commun. · 2020 · 11 · 112610.1038/s41467-020-14963-0 ↗
27. Tang · Nano Lett. · 2019 · 19 · 447010.1021/acs.nanolett.9b01282 ↗
28. Vestweber · Nat. Rev. Immunol. · 2015 · 15 · 69210.1038/nri3908 ↗
29. Schnoor · Mediators Inflammation · 2015 · 2015 · 94650910.1155/2015/946509 ↗
30. Nourshargh · Immunity · 2014 · 41 · 69410.1016/j.immuni.2014.10.008 ↗
31. Van Hoecke · J. Visualized Exp. · 2017 · e55398
32. Roos · J. Visualized Exp. · 2014 · e51470
33. Mercer · Am. J. Respir. Cell Mol. Biol. · 2013 · 50 · 14410.1165/rcmb.2013-0142OC ↗
34. Basu · Blood · 2002 · 100 · 85410.1182/blood.V100.3.854 ↗
35. Suratt · Am. J. Physiol.: Lung Cell. Mol. Physiol. · 2001 · 281 · L913
36. Dancey · J. Clin. Invest. · 1976 · 58 · 70510.1172/JCI108517 ↗
37. Li · J. Biol. Chem. · 2012 · 287 · 2535310.1074/jbc.M112.349126 ↗
38. Johansen · Nat. Commun. · 2016 · 7 · 1097410.1038/ncomms10974 ↗
39. Evensen · Nanoscale · 2016 · 8 · 86210.1039/C5NR07289A ↗
40. Fenaroli · ACS Nano · 2014 · 8 · 701410.1021/nn5019126 ↗
41. Corbo · ACS Nano · 2017 · 11 · 326210.1021/acsnano.7b00376 ↗
42. Sosale · Curr. Opin. Immunol. · 2015 · 35 · 10710.1016/j.coi.2015.06.013 ↗
43. Hu · Proc. Natl. Acad. Sci. U. S. A. · 2011 · 108 · 1098010.1073/pnas.1106634108 ↗
44. Desilets · Anticancer Res. · 2001 · 21 · 1741
45. Suk · Adv. Drug Delivery Rev. · 2016 · 99 · 2810.1016/j.addr.2015.09.012 ↗
46. Gref · Science · 1994 · 263 · 160010.1126/science.8128245 ↗
47. Abuchowski · J. Biol. Chem. · 1977 · 252 · 358210.1016/S0021-9258(17)40292-4 ↗
48. Acharya · Adv. Drug Delivery Rev. · 2011 · 63 · 17010.1016/j.addr.2010.10.008 ↗
49. Sindhwani · Nat. Mater. · 2020 · 19 · 56610.1038/s41563-019-0566-2 ↗
50. Naumenko · Acta Biomater. · 2020 · 104 · 17610.1016/j.actbio.2020.01.011 ↗
51. Hao · Drug Delivery · 2020 · 27 · 110.1080/10717544.2019.1701141 ↗
52. Miller · Nat. Commun. · 2015 · 6 · 869210.1038/ncomms9692 ↗
53. Smith · Nat. Nanotechnol. · 2014 · 9 · 48110.1038/nnano.2014.62 ↗
54. Fromen · ACS Nano · 2017 · 11 · 1079710.1021/acsnano.7b03190 ↗
55. de Oliveira · Nat. Rev. Immunol. · 2016 · 16 · 37810.1038/nri.2016.49 ↗